Display options
Cite
Biello KB, Psaros C, Krakower DS, et al. A Pre-Exposure Prophylaxis Adherence Intervention (LifeSteps) for Young Men Who Have Sex With Men: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2019;8(1):e10661doi: 10.2196/10661.
Biello, K. B., Psaros, C., Krakower, D. S., Marrow, E., Safren, S. A., Mimiaga, M. J., Hightow-Weidman, L., Sullivan, P., & Mayer, K. H. (2019). A Pre-Exposure Prophylaxis Adherence Intervention (LifeSteps) for Young Men Who Have Sex With Men: Protocol for a Pilot Randomized Controlled Trial. JMIR research protocols, 8(1), e10661. https://doi.org/10.2196/10661
Biello, Katie B, et al. "A Pre-Exposure Prophylaxis Adherence Intervention (LifeSteps) for Young Men Who Have Sex With Men: Protocol for a Pilot Randomized Controlled Trial." JMIR research protocols vol. 8,1 (2019): e10661. doi: https://doi.org/10.2196/10661
Biello KB, Psaros C, Krakower DS, Marrow E, Safren SA, Mimiaga MJ, Hightow-Weidman L, Sullivan P, Mayer KH. A Pre-Exposure Prophylaxis Adherence Intervention (LifeSteps) for Young Men Who Have Sex With Men: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2019 Jan 29;8(1):e10661. doi: 10.2196/10661. PMID: 30694206; PMCID: PMC6371073.
Copy Download .nbib Format: NLM
Share it on

JMIR Res Protoc. 2019 Jan 29;8(1):e10661. doi: 10.2196/10661.

A Pre-Exposure Prophylaxis Adherence Intervention (LifeSteps) for Young Men Who Have Sex With Men: Protocol for a Pilot Randomized Controlled Trial.

JMIR research protocols

Katie B Biello, Christina Psaros, Douglas S Krakower, Elliot Marrow, Steven A Safren, Matthew J Mimiaga, Lisa Hightow-Weidman, Patrick Sullivan, Kenneth H Mayer

Affiliations

  1. Center for Health Equity Research, Brown University School of Public Health, Providence, RI, United States.
  2. Department of Behavioral & Social Sciences, Brown University School of Public Health, Providence, RI, United States.
  3. The Fenway Institute, Fenway Health, Boston, MA, United States.
  4. Department of Epidemiology, Brown University School of Public Health, Providence, RI, United States.
  5. Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
  6. Department of Psychology, Harvard Medical School, Boston, MA, United States.
  7. Department of Medicine, Harvard Medical School, Boston, MA, United States.
  8. Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, United States.
  9. Department of Psychology, University of Miami, Coral Gables, FL, United States.
  10. Behavior and Technology Lab, Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  11. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
  12. Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, United States.

PMID: 30694206 PMCID: PMC6371073 DOI: 10.2196/10661

Abstract

BACKGROUND: New HIV infections occur at a disproportionately high rate among young men who have sex with men (YMSM). It is, therefore, essential that comprehensive HIV prevention strategies, specifically tailored to their needs and perceptions, are developed, tested, and disseminated. Antiretroviral pre-exposure prophylaxis (PrEP) is effective in decreasing HIV transmission among men who have sex with men; however, adherence is critical to its efficacy. In open-label studies among YMSM, adherence was suboptimal. Hence, behavioral approaches that address the unique challenges to YMSM PrEP adherence are needed.

OBJECTIVE: This study aims to describe the protocol for intervention refinement and a pilot randomized controlled trial (RCT) of a PrEP adherence intervention, LifeSteps for pre-exposure prophylaxis for young men who have sex with men (LSPY).

METHODS: This study includes the following 2 phases: formative qualitative interviews with approximately 20 YMSM and 10 key informants for intervention adaptation and refinement and a pilot RCT of up to 50 YMSM to assess the feasibility, acceptability, and preliminary efficacy of the LSPY, compared with the PrEP standard of care, to improve PrEP adherence. Participants will be recruited at 3 iTech subject recruitment venues in the United States.

RESULTS: Phase 1 is expected to begin in June 2018, and enrollment of phase 2 is anticipated to begin in early 2019.

CONCLUSIONS: Few rigorously developed and tested interventions have been designed to increase PrEP adherence among YMSM in community settings, despite this population's high HIV incidence. The long-term goal of this intervention is to develop scalable protocols to optimize at-risk YMSM's PrEP uptake and adherence to decrease the HIV incidence.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/10661.

©Katie B Biello, Christina Psaros, Douglas S Krakower, Elliot Marrow, Steven A Safren, Matthew J Mimiaga, Lisa Hightow-Weidman, Patrick Sullivan, Kenneth H Mayer. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 29.01.2019.

Keywords: HIV prevention; adherence; adolescents; antiretroviral pre-exposure prophylaxis; men who have sex with men

References

  1. Health Serv Res. 2000 Feb;34(6):1273-302 - PubMed
  2. Am J Public Health. 2001 Jun;91(6):892-4 - PubMed
  3. Behav Res Ther. 2001 Oct;39(10):1151-62 - PubMed
  4. AIDS. 2006 Jan 9;20(2):253-60 - PubMed
  5. J Behav Med. 2007 Oct;30(5):359-70 - PubMed
  6. Curr HIV/AIDS Rep. 2007 Dec;4(4):201-7 - PubMed
  7. Am J Prev Med. 2009 Feb;36(2):165-73 - PubMed
  8. Health Psychol. 2009 Jan;28(1):1-10 - PubMed
  9. Transcult Psychiatry. 2009 Jun;46(2):238-56 - PubMed
  10. Epidemiol Rev. 2010;32:56-69 - PubMed
  11. N Engl J Med. 2010 Dec 30;363(27):2587-99 - PubMed
  12. AIDS. 2011 Mar 27;25(6):825-34 - PubMed
  13. Sci Transl Med. 2012 Sep 12;4(151):151ra125 - PubMed
  14. AIDS Patient Care STDS. 2013 Apr;27(4):248-54 - PubMed
  15. Cogn Behav Pract. 2013 May;20(2):202-212 - PubMed
  16. PLoS Med. 2013;10(9):e1001511 - PubMed
  17. J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):522-9 - PubMed
  18. JAMA. 2014 Jul 2;312(1):85-6 - PubMed
  19. Lancet Infect Dis. 2014 Sep;14(9):820-9 - PubMed
  20. Vulnerable Child Youth Stud. 2014 Jul 1;9(3):279-290 - PubMed
  21. Cogn Behav Pract. 2014 May;21(2):191-205 - PubMed
  22. J Int AIDS Soc. 2015 Feb 26;18(2 Suppl 1):19434 - PubMed
  23. J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):234-40 - PubMed
  24. Clin Infect Dis. 2015 Nov 15;61(10):1601-3 - PubMed
  25. Lancet. 2016 Jan 2;387(10013):53-60 - PubMed
  26. Transl Behav Med. 2015 Dec;5(4):470-82 - PubMed
  27. N Engl J Med. 2015 Dec 3;373(23):2237-46 - PubMed
  28. J Acquir Immune Defic Syndr. 2016 May 1;72(1):79-86 - PubMed
  29. J Urban Health. 2016 Feb;93(1):189-205 - PubMed
  30. J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):21-29 - PubMed
  31. AIDS Behav. 2017 May;21(5):1350-1360 - PubMed
  32. Cogn Behav Pract. 2017 Feb;24(1):38-49 - PubMed
  33. JAMA Pediatr. 2017 Nov 1;171(11):1063-1071 - PubMed
  34. J Clin Epidemiol. 1999 Jan;52(1):19-26 - PubMed

Publication Types

Grant support